Literature DB >> 8509438

Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.

R Klän1, H H Knispel, T Meier.   

Abstract

We examined the effect of acetylsalicylic acid (ASA) on n-butyl-(4-hydroxybutyl)nitrosamine (BHBN)-induced bladder carcinogenesis in male Wistar rats. Of 29 rats that received 0.05% BHBN in their drinking water for 9 weeks, 8 developed bladder cancer. Only 1 out of 29 rats that received 0.1% ASA in their diet for 20 weeks, including the period of BHBN consumption, developed a tumor. That difference is statistically significant. Bladder weight was significantly higher in rats given BHBN than in controls and in rats given both BHBN and ASA. We conclude that ASA inhibits BHBN-induced bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509438     DOI: 10.1007/BF01215929

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer.

Authors:  A Danon; T V Zenser; D L Thomasson; B B Davis
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

2.  Combination chemoprevention of rat mammary carcinogenesis by indomethacin and butylated hydroxytoluene.

Authors:  D L McCormick; A M Wilson
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

3.  Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double blind multicenter trial in Switzerland.

Authors:  U E Studer; C Biedermann; D Chollet; P Karrer; R Kraft; H Toggenburg; F Vonbank
Journal:  J Urol       Date:  1984-01       Impact factor: 7.450

Review 4.  Bladder cancer epidemiology.

Authors:  G M Matanoski; E A Elliott
Journal:  Epidemiol Rev       Date:  1981       Impact factor: 6.222

5.  Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis.

Authors:  T V Zenser; M B Mattammal; R W Wise; J R Rice; B B Davis
Journal:  J Pharmacol Exp Ther       Date:  1983-12       Impact factor: 4.030

6.  Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.

Authors:  T V Zenser; M O Palmier; M B Mattammal; R I Bolla; B B Davis
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

7.  Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding.

Authors:  M B Mattammal; T V Zenser; B B Davis
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

Review 8.  The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.

Authors:  I B Weinstein
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

9.  Indomethacin and poly I:C in the inhibition of carcinogen-induced bladder cancer in an experimental animal model.

Authors:  M J Droller; D Gomolka
Journal:  J Urol       Date:  1984-06       Impact factor: 7.450

10.  ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.

Authors:  M V Viola; F Fromowitz; S Oravez; S Deb; J Schlom
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

2.  Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database.

Authors:  M J Langman; K K Cheng; E A Gilman; R J Lancashire
Journal:  BMJ       Date:  2000-06-17

3.  Non-steroidal anti-inflammatory drugs and bladder cancer prevention.

Authors:  J E Castelao; J M Yuan; M Gago-Dominguez; M C Yu; R K Ross
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.